E
FibroGen, Inc. FGEN
$10.48 $0.131.26% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -263.89% -74.20% 205.26% -9.91% 52.80%
Total Depreciation and Amortization -32.42% -7.10% -52.37% -5.38% -4.76%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -33.25% 433.50% -107.82% 78.21% 6.56%
Change in Net Operating Assets 414.77% 88.17% -837.95% 84.30% 4.75%
Cash from Operations 366.42% 108.92% -263.73% 78.99% 32.75%
Capital Expenditure 18.75% 88.65% -71.95% -485.71% 51.72%
Sale of Property, Plant, and Equipment -- -- -75.39% 27,800.00% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -100.00% 40.82%
Cash from Investing 18.75% -100.93% 128.21% -98.95% 40.88%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 160.00% -25.00% 75.00% -100.00% 33.33%
Issuance of Common Stock -- -- -- -100.00% --
Repurchase of Common Stock 67.57% -164.29% 87.39% -46.05% 50.33%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -- -- -- --
Cash from Financing 89.77% -1,860.00% 103.94% -496.88% 119.39%
Foreign Exchange rate Adjustments -30.28% 1,717.24% 95.57% -176.14% 1,056.05%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 239.16% 113.95% -196.83% -127.76% 539.78%